Skip to content Skip to navigation

Medical Services

Printer-friendly version

Editors Picks

Methadone remains vital in buprenorphine era

October 20, 2016  |  Alison Knopf, Contributing Writer
Opioid treatment leaders see the two main medication treatments for opioid use disorders as complementary options.

A treatment that can break clinician-patient barriers

October 17, 2016  |  David Suomela, DOM, AP
Exposing both patients and staff to the benefits of acupuncture can promote healthy coping.

Kratom research sorely needed for clinical, policy decisions

October 13, 2016  |  Julie Miller, Editor in Chief
The Drug Enforcement Administration (DEA) has slowed its move to place kratom on its most restrictive scheduling, as members of the research community argue against blocking studies of possible analgesic benefits.

Younger adult overdoses on the rise in Virginia

September 21, 2016  |  Tom Valentino, Senior Editor
Adults ages 25 to 44 accounted for more than half of all drug overdose-related deaths in Virginia from 2007 to 2014, according to research published this week.

Alkermes establishes grant program for nonprofits

September 16, 2016  |  Gary A. Enos, Editor
The maker of injectable naltrexone has announced an initiative in which nonprofit organizations may apply for funding to improve addiction and mental health systems of care.

Conference report: Presenter shows unbridled enthusiasm for methadone, buprenorphine

September 10, 2016  |  Gary A. Enos, Editor
A physician presenting at the Cape Cod Symposium on Addictive Disorders endorsed much wider access to both methadone and buprenorphine treatment for opioid dependence.

ASAM releases patient guide to opioid addiction treatment

September 2, 2016  |  Gary A. Enos, Editor
Assessment, treatment planning and medical interventions are addressed in the American Society of Addiction Medicine's (ASAM's) opioid treatment guide for patients and families.

Some doctors pursuing genetic clues to medication response or misuse

September 1, 2016  |  Gary A. Enos, Editor
Predictive testing to evaluate the potential risks and benefits of opioids and other medications appears to have wide applicability in many sectors of healthcare.

FDA mandates warnings, education on use of opioids with benzodiazepines

September 1, 2016  |  Gary A. Enos, Editor
Based partly on findings of increases in overdoses from concurrent prescribing of opioids and benzodiazepines, the Food and Drug Administration (FDA) is requiring boxed warnings and patient guides for nearly 400 individual drugs.

Acupuncture helps keep patients in treatment

August 20, 2016  |  Tom Valentino, Senior Editor
The National Acupuncture Detoxification Association’s 5-point ear acupuncture protocol is not a standalone replacement for other forms of addiction treatment, but when used in conjunction with those programs, it can increase their effectiveness.

Government retains marijuana's Schedule I classification

August 11, 2016  |  Gary A. Enos, Editor
Today's announcement by the Drug Enforcement Administration (DEA) did include an indication that federally sanctioned marijuana research opportunities could expand.